Vital Signals introduced the Signal Ring, a wearable device that aims to provide accurate blood pressure readings without the traditional cuff or calibration process. Preorders began in July with shipments expected in October.
- Signal Ring offers cuffless, calibration-free blood pressure tracking from the finger
- Tested in a 451-person clinical study, meeting international cuff standards
- Experts urge caution until more data validates accuracy claims
What happened
Vital Signals launched the Signal Ring priced at $399, a smart ring that promises to continuously track blood pressure without needing an inflatable cuff or frequent calibration. The company claims its device works four to five times faster than traditional cuffs and meets international accuracy standards based on results from a 451-person clinical study. The ring pairs with a companion app to deliver readings and is available for preorder now, with initial shipments expected to start in October.
This innovation aims to provide a less intrusive and more continuous blood pressure measurement solution, a significant advancement as nearly half of U.S. adults have hypertension. Unlike traditional wrist or arm cuff monitors, this ring collects data from the finger, potentially improving user convenience and adherence to monitoring routines.
Why it matters
High blood pressure is a leading risk factor for stroke and cardiovascular diseases, making regular monitoring critical for effective management. Existing wearable devices either rely on cuff-based mechanisms or provide indirect cardiovascular metrics without claiming to replace standard blood pressure cuffs. The Signal Ring’s promise of accurate, cuffless, and calibration-free monitoring could transform daily health tracking for hypertensive patients and reduce the burden of routine measurements.
However, medical experts express skepticism about the device’s technology and accuracy, suspecting it relies on photoplethysmography (PPG) sensors, which face challenges such as interference from motion, skin tone variability, and circulation differences. Such factors could produce inaccurate readings, potentially causing mismanagement of hypertension if relied on without clinical validation.
What to watch next
The success of the Signal Ring depends on further independent testing and transparency from Vital Signals regarding the technology and data supporting their accuracy claims. Additional clinical validation will be critical to confirm whether this wearable can reliably replace or complement traditional cuff monitors in everyday settings. Users should also watch for regulatory reviews or FDA clearance, which the product has not yet received.
Healthcare professionals caution patients to consult their doctors before integrating devices like the Signal Ring into their hypertension management. Continuous data tracking could unveil blood pressure trends missed by infrequent measurements but must be interpreted within a comprehensive treatment plan. If proven reliable, this device could lead to earlier detection of blood pressure changes and improved personalized care.